Inhibiting the herpes simplex virus type 1 viral enzyme uracil-DNA glycosylase reactivates the natural defense protein apolipoprotein B mRNA editing enzyme, catalytic polypeptide-1 (APOBEC1) in the ...

Alfasigma S.p.A. ("Alfasigma"), a global pharmaceutical company, and Innovative Molecules GmbH ("Innovative Molecules"), a clinical-stage biotechnology company, today announced a strategic partnership ...

Prior to the 1970s, researchers widely believed cervical cancer was caused by the herpes simplex virus. That understanding ...

Members of a new class of antivirals are being tested in U.S. clinical trials, and one has gained approval in Japan, but how ...

Pritelivir demonstrated clinically meaningful and highly statistically significant superiority (p=0.0047) in lesion healing up to 28 days of treatment, compared with standard-of-care (SoC) treatments ...

While it may give billions of people worldwide painful cold sores, a common virus could be harnessed to provide a much-need new cancer treatment. This is the conclusion of a study by researchers with ...

Researchers at Mass General Brigham have modified a herpes simplex virus (HSV-1) that stimulates the immune system to attack glioblastoma cells. A single dose of the modified virus increased T-cell, ...

Laura holds a Master's in Experimental Neuroscience and a Bachelor's in Biology from Imperial College London. Her areas of expertise include health, medicine, psychology, and neuroscience.View full ...

This is read by an automated voice. Please report any issues or inconsistencies here. Cancer-fighting, genetically engineered herpes simplex virus has been shown to be an effective treatment for ...

For many years, scientists have known that the herpes simplex virus-1 (HSV-1), which causes cold sores, can take up residence in parts of neurons in the peripheral nervous system. Stress can even ...